Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

NVS
Novartis AG - ADR
stock NYSE ADR

At Close
2/3/2023 4:00:01 PM EST
85.85USD-0.290%(-0.25)3,891,241
85.82Bid   85.84Ask   0.02Spread IEX
Pre-market
2/3/2023 9:23:30 AM EST
86.07USD-0.035%(-0.03)10
After-hours
2/3/2023 4:00:30 PM EST
85.85USD+0.012%(+0.01)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
206.359B
Headquarters
Basel, Basel Stadt, Switzerland
Industry
Drug Manufacturers-General
Last Dividend
2022-03-082.182
Last Split
2019-04-091.11607143for1
Related
GSKABTBMYJNJPFESNYMRKTEVAXLV
NVS Stats
Avg. Vol. 10 Day
2,446,987
Avg. Vol. 30 Day
2,247,212
Dividend Yield
3.769%
Dividend Rate (ttm)
3.325
Employees
108,000
Market Cap
206,359,469,484
Shares Out.
2,403,721,252
Float
2,048,553,850
P/E Ratio
9.73
EPS (ttm)
9.810
On/Off Exchange
69%/31%
6 Month Beta
0.39
1 Year Beta
0.40
2 Year Beta
0.39
3 Year Beta
0.55
52 Week Low
74.09
52 Week High
94.26
SMA50
91.01
SMA200
84.67
1 Week
-4.23%
1 Month
-5.45%
3 Month
+5.05%
6 Month
+0.33%
1 Year
-0.50%
2 Year
-5.17%
5 Year
+1.20%
Jan 31, 2022
04:51PM EST  Amgen Reports In 8K Filing Co Entered Into Amendment No. 3 To Exclusive License & Collaboration Agreement With Novartis   Benzinga
Jan 26, 2022
08:00AM EST  Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announces the appointment of Cintia Piccina as Chief Commercial Officer effective January 31, 2022.   GlobeNewswire Inc
Jan 18, 2022
04:25AM EST  Molecular Partners Finalized License Agreement with Novartis for Ensovibep for COVID-19; Molecular Partners to Receive Milestone Payment of CHF150M, 22% Royalty on Ensovibep Sales in Relevant Territories   Benzinga
01:26AM EST  Molecular Partners AG (MOLN), a clinical-stage biotech company developing DARPin therapeutics, Tuesday said it has entered into a license agreement with Novartis AG (NVS), under which the Swiss drug major will in-license global rights to ensovibep from Molecular Partners.   RTTNews
01:12AM EST  Molecular Partners Finalizes License Deal With Novartis For Ensovibep For COVID-19   RTTNews
More News
Profile
Novartis AG is a Swiss-American multinational pharmaceutical corporation based in Basel, Switzerland and Cambridge, Massachusetts, United States. It is one of the largest pharmaceutical companies in the world.

NVS Stock Summary

Novartis AG - ADR (NYSE:NVS) stock price today is $85.85, and today's volume is 3,891,241. NVS is down -0.290% today. The 30 day average volume is 2,247,212. NVS market cap is 206.359B with 2,403,721,252 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC